220 related articles for article (PubMed ID: 19949065)
1. The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth.
Büchau AS; Morizane S; Trowbridge J; Schauber J; Kotol P; Bui JD; Gallo RL
J Immunol; 2010 Jan; 184(1):369-78. PubMed ID: 19949065
[TBL] [Abstract][Full Text] [Related]
2. Host Cathelicidin Exacerbates Group B
Patras KA; Coady A; Babu P; Shing SR; Ha AD; Rooholfada E; Brandt SL; Geriak M; Gallo RL; Nizet V
mSphere; 2020 Apr; 5(2):. PubMed ID: 32321824
[TBL] [Abstract][Full Text] [Related]
3. Cathelicidin deficiency predisposes to eczema herpeticum.
Howell MD; Wollenberg A; Gallo RL; Flaig M; Streib JE; Wong C; Pavicic T; Boguniewicz M; Leung DY
J Allergy Clin Immunol; 2006 Apr; 117(4):836-41. PubMed ID: 16630942
[TBL] [Abstract][Full Text] [Related]
4. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
[TBL] [Abstract][Full Text] [Related]
5. Cod cathelicidin: isolation of the mature peptide, cleavage site characterisation and developmental expression.
Broekman DC; Frei DM; Gylfason GA; Steinarsson A; Jörnvall H; Agerberth B; Gudmundsson GH; Maier VH
Dev Comp Immunol; 2011 Mar; 35(3):296-303. PubMed ID: 20950641
[TBL] [Abstract][Full Text] [Related]
6. NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo.
Grundy MA; Zhang T; Sentman CL
Cancer Immunol Immunother; 2007 Aug; 56(8):1153-61. PubMed ID: 17160409
[TBL] [Abstract][Full Text] [Related]
7. Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin.
Di Nardo A; Yamasaki K; Dorschner RA; Lai Y; Gallo RL
J Immunol; 2008 Jun; 180(11):7565-73. PubMed ID: 18490758
[TBL] [Abstract][Full Text] [Related]
8. Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus.
Kitajima M; Abe T; Miyano-Kurosaki N; Taniguchi M; Nakayama T; Takaku H
Mol Ther; 2008 Feb; 16(2):261-8. PubMed ID: 18059370
[TBL] [Abstract][Full Text] [Related]
9. The role of cathelicidins in the innate host defenses of mammals.
Zanetti M
Curr Issues Mol Biol; 2005 Jul; 7(2):179-96. PubMed ID: 16053249
[TBL] [Abstract][Full Text] [Related]
10. Defective antitumor responses in CX3CR1-deficient mice.
Yu YR; Fong AM; Combadiere C; Gao JL; Murphy PM; Patel DD
Int J Cancer; 2007 Jul; 121(2):316-22. PubMed ID: 17372897
[TBL] [Abstract][Full Text] [Related]
11. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
12. Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli.
Schauber J; Dorschner RA; Yamasaki K; Brouha B; Gallo RL
Immunology; 2006 Aug; 118(4):509-19. PubMed ID: 16895558
[TBL] [Abstract][Full Text] [Related]
13. Cathelicidins from the bullfrog Rana catesbeiana provides novel template for peptide antibiotic design.
Ling G; Gao J; Zhang S; Xie Z; Wei L; Yu H; Wang Y
PLoS One; 2014; 9(3):e93216. PubMed ID: 24675879
[TBL] [Abstract][Full Text] [Related]
14. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of tumor infiltrating lymphocyte clones derived from B16-F10 murine melanoma.
Maeda K; Lafreniere R; Jerry LM
J Invest Dermatol; 1991 Aug; 97(2):183-9. PubMed ID: 2071934
[TBL] [Abstract][Full Text] [Related]
16. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin.
Yamasaki K; Schauber J; Coda A; Lin H; Dorschner RA; Schechter NM; Bonnart C; Descargues P; Hovnanian A; Gallo RL
FASEB J; 2006 Oct; 20(12):2068-80. PubMed ID: 17012259
[TBL] [Abstract][Full Text] [Related]
17. Murine B16 melanoma vaccination-induced tumor immunity: identification of specific immune cells and functions involved.
Wu TY; Fleischmann WR
J Interferon Cytokine Res; 2001 Dec; 21(12):1117-27. PubMed ID: 11798470
[TBL] [Abstract][Full Text] [Related]
18. Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance.
Hofmann MH; Mani R; Engelhardt H; Impagnatiello MA; Carotta S; Kerenyi M; Lorenzo-Herrero S; Böttcher J; Scharn D; Arnhof H; Zoephel A; Schnitzer R; Gerstberger T; Sanderson MP; Rajgolikar G; Goswami S; Vasu S; Ettmayer P; Gonzalez S; Pearson M; McConnell DB; Kraut N; Muthusamy N; Moll J
Mol Cancer Ther; 2020 Apr; 19(4):1018-1030. PubMed ID: 32024684
[TBL] [Abstract][Full Text] [Related]
19. NK1.1+ cells mediate the antitumor effects of a dual Toll-like receptor 7/8 agonist in the disseminated B16-F10 melanoma model.
Dumitru CD; Antonysamy MA; Gorski KS; Johnson DD; Reddy LG; Lutterman JL; Piri MM; Proksch J; McGurran SM; Egging EA; Cochran FR; Lipson KE; Tomai MA; Gullikson GW
Cancer Immunol Immunother; 2009 Apr; 58(4):575-87. PubMed ID: 18791716
[TBL] [Abstract][Full Text] [Related]
20. Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis.
Morioka Y; Yamasaki K; Leung D; Gallo RL
J Immunol; 2008 Sep; 181(6):3915-22. PubMed ID: 18768846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
